NLOP

NLOP is not a going-concern growth story — it is a liquidating office-REIT vehicle carved out of W.P. Carey, and the numbers read like a wind-down. Revenue has fallen four straight years from $175M (FY2023) to $119M (FY2025, -16.4% YoY) as assets are sold, and total assets dropped -43.7% to $453M in a single year. The headline -$145M net loss and -122% net margin look catastrophic, but they are dominated by non-cash real-estate impairments (the MD&A's undiscounted-cash-flow, 'less costs to sell' impairment language, plus the FY2023/24/25 string of -$132M/-$91.5M/-$145M losses), not operating collapse — operating cash flow was still positive at $64.1M. The real signal is the balance sheet: long-term debt was slashed -87.1% to $21.9M, cash ballooned +376% to $120M (73% of the entire $165M market cap), and liabilities/equity sits at a conservative 0.53x. Management is clearly selling buildings, retiring debt, and hoarding cash.

The bull case is the discount: $294M of equity against a $165M market cap is ~0.56x book, or roughly $19.9/share of stated equity versus an $11.16 price. If assets liquidate near carrying value, there is meaningful upside, and the ~$45.9M of dividends paid (~$3/share) is effectively return of capital while you wait. The problem is that office book value is exactly the number in question. The same impairment machinery that wrote down $145M last year is still running, the critical-accounting-estimate disclosure flags continued reliance on 'market rents, residual values, and holding periods' for office assets in a weak office market, and each write-down closes the book-to-price gap from the wrong direction. FY2025's book equity is already down -49.4% YoY.